NAD+ injections bypass digestion, while oral NAD-support supplements such as nicotinamide riboside (NR) or nicotinamide mononucleotide (NMN) must be absorbed and converted by the body. Oral precursors have human evidence for raising NAD-related biomarkers, but clinical outcome data are limited. No NAD+ form is proven to extend human lifespan or specifically reduce belly fat.
Wondering if NAD+ is right for you? Take the 3-min clinical quiz.
See if you qualify →What is the quick answer on NAD+ injections vs oral NAD+?
The practical answer is this: NAD+ injections deliver NAD+ without going through the gut, while oral NAD-support products rely on digestion, absorption, and conversion. That may make injections more direct, but it does not prove they are better for every person or every goal.
For patients, the choice usually comes down to route, supervision, safety, and evidence. Oral products are easy to buy and use, while injections require sterile compounding and clinician oversight. Human studies of NAD+ precursors often measure biomarkers, not hard outcomes like lifespan, disease prevention, or body-fat loss 1.
- Injection: bypasses digestion and is usually clinician-guided when prescribed.
- Oral precursor: often NR, NMN, or nicotinamide; must be absorbed and metabolized.
- Nasal spray: a non-injection route sometimes used in compounded care, with less human outcomes research than oral precursors.
- IV infusion: direct IV delivery, usually visit-based and monitored; it is not the same as a take-home injection.
What is NAD+ and why are people taking it?
NAD+ is short for nicotinamide adenine dinucleotide. It helps cells turn food into ATP, the energy currency your cells use, and it is involved in normal mitochondrial function and DNA repair-related pathways 2.
NAD+ also works with enzyme families such as sirtuins and PARP enzymes. Sirtuins are linked to stress-response and metabolic signaling, while PARP enzymes use NAD+ during DNA damage responses 2. These mechanisms are why NAD+ is discussed in aging biology and longevity research.
But mechanism is not the same as proof. A pathway can look important in cells, animals, or biomarkers without proving that a treatment makes humans live longer. Current reviews describe NAD+ biology as promising but still uneven across routes, populations, and outcomes 1, 3.
How do oral NAD+ supplements work?
Most oral “NAD+” products are actually NAD+ precursors, such as NR, NMN, or nicotinamide, also called NAM. The body absorbs these vitamin B3 derivatives and uses metabolic steps to contribute to NAD+ pathways 1.
NAD+ vs NAD+ precursors
Nicotinamide riboside, or NR, has been tested in human studies. In a 2016 human study, single oral NR doses increased blood NAD+ metabolites, showing that oral NR can enter NAD-related pathways in people 4.
Nicotinamide mononucleotide, or NMN, has also been studied in humans. In a randomized trial of postmenopausal women with prediabetes, NMN improved skeletal-muscle insulin signaling, but the trial did not prove weight loss or lifespan extension 6.
Why digestion matters
Oral products must pass through digestion and metabolism before they can affect NAD-related pools. That means bioavailability may vary by product, person, gut function, and the specific precursor used 1.
Convenience is the main advantage. Oral supplements are non-invasive and fit easily into a daily routine. The trade-off is that supplement quality varies, and most human studies focus on blood or tissue biomarkers rather than clear symptom, weight, or longevity outcomes 3.
How do NAD+ injections work?
NAD+ injections are designed to deliver NAD+ without first passing through the digestive tract. That can make the delivery route more direct than oral precursors, but direct delivery is not the same as proven superiority for energy, cognition, weight loss, or longevity.
The key safety issue is sterility. FDA has warned that food-grade NAD+ ingredients are not suitable for sterile compounding without appropriate processing because microbes and endotoxins can harm patients 8. FDA has also received adverse event reports after NAD+ injectable drugs, including severe chills, shaking, vomiting, and fatigue, with some cases needing medical treatment 8.
This is why we focus on the licensed path: clinician evaluation, sterile compounding standards, and state-licensed 503A pharmacy dispensing. Self-directed injections from no-prescription or “research chemical” sources add avoidable risk.
3-min quiz
Considering clinician-guided NAD+?
At Chia, NAD+ is available as injection or nasal spray after an online health questionnaire and review by a licensed US provider. A prescription requires a medical evaluation and is not guaranteed. Compounded medications are not FDA-approved.
Is NAD+ injection better than oral NAD+?
There is no single best form for everyone. Injection, oral, nasal, and IV NAD+ routes differ in convenience, supervision, absorption assumptions, and safety needs, but current human evidence does not prove one route is best for all healthy adults.
| Route | What it is | Main advantage | Main limitation | Evidence level |
|---|---|---|---|---|
| Oral NR, NMN, or NAM | NAD+ precursors taken by mouth | Convenient and non-invasive | Must pass through digestion and metabolism; supplement quality varies | Human trials show biomarker changes; clinical outcome data are limited |
| NAD+ injection | Injected NAD+ that bypasses digestion | Clinician-guided route may offer more controlled delivery | Requires sterile compounding and medical review; injection reactions and contamination risks matter | Less direct human outcomes evidence than oral precursor biomarker studies |
| NAD+ nasal spray | Nasal compounded route | Non-injection option for eligible patients | Limited human outcomes data for longevity claims | Evidence is still developing |
| NAD+ IV infusion | NAD+ delivered by intravenous infusion | Direct IV delivery with visit-based monitoring | More time-intensive and not the same as take-home injection | Human outcomes data remain limited |
In short, oral precursors have more published human biomarker studies, while injections offer a route that bypasses the gut. Neither fact proves better real-world outcomes for every patient. Benefits, side effects, contraindications, and monitoring should be considered together 1, 8.
What does the human evidence say about NAD+ for energy, metabolism, and longevity?
The human evidence is strongest for NAD-related biomarker changes, not for proven human lifespan extension. Some trials show oral precursors can raise NAD+ metabolites or affect metabolic markers, but results vary by study and population.
Human randomized evidence
In a randomized trial of healthy middle-aged and older adults, chronic NR supplementation was reported to be well tolerated and increased NAD+ metabolism markers, but the study was not designed to prove longer life 5. In obese insulin-resistant men, another randomized trial found NR did not improve insulin sensitivity or several metabolic health measures 7.
For NMN, a randomized trial in postmenopausal women with prediabetes found improved muscle insulin sensitivity and insulin signaling, but this does not mean NMN is a proven weight-loss or anti-aging treatment 6. A separate randomized study in older men reported that oral NMN affected some physical performance measures, but it did not prove lifespan extension 9. Individual results vary.
Human observational, animal, and cell evidence
Human observational evidence can show associations between NAD-related biology and health states, but it cannot prove that taking NAD+ changes an outcome. Animal and cell studies help explain mechanisms, such as mitochondrial signaling and DNA repair pathways, but they should not be treated as proof of human longevity benefits 3.
The honest bottom line: NAD+ research is biologically interesting. It is not proof that NAD+ injections, oral precursors, nasal spray, or IV therapy extend human lifespan.
Does NAD+ reduce belly fat or cause weight loss?
No NAD+ route should be framed as a stand-alone belly fat or weight-loss treatment. Some NAD+ precursor studies look at insulin signaling or metabolic markers, but those are not the same as proven body-fat reduction 6, 7.
If weight loss is the main goal, it deserves its own medical evaluation. At Chia, weight-related care is handled through clinician-guided plans that may include GLP-1 treatment when appropriate, not by presenting NAD+ as a fat-loss shortcut. Our Weight + Energy protocol combines NAD+ injection with a choice of GLP-1 for eligible patients after provider review.
What about celebrity NAD+ trends?
Searches like “what NAD do the Kardashians use” are common, but celebrity use is not medical evidence. A treatment can be popular online and still have limited human outcomes data.
A better filter is simple: ask what route was used, whether it was clinician-guided, whether the product came from a licensed source, what outcome was measured, and whether that outcome was a biomarker or something patients can actually feel. Influencer anecdotes cannot answer those questions.
NAD+ support at Chia: injections or nasal spray after clinician review
At Chia, we offer NAD+ as an injection and as a nasal spray for eligible patients. Plans currently start at $179/mo for NAD+ injection and $119/mo for NAD+ nasal spray; see the product page for up-to-date pricing.
Care starts online with a short health questionnaire. A licensed US provider reviews your health history, medications, goals, symptoms, and safety factors, then prescribes only when clinically appropriate. Dosing is provider-guided and adjusted over time through the patient portal.
| Chia option | Form | Current starting price | How it may fit |
|---|---|---|---|
| NAD+ | Injection | From $179/mo | For eligible patients comfortable with provider-guided injections |
| NAD+ | Nasal spray | From $119/mo | For eligible patients who prefer a non-injection route |
| Foundation Longevity | Sermorelin Injection + NAD+ Injection + Glutathione Injection | From $399/mo | A multi-treatment longevity protocol after clinician review |
| Glow | GHK-Cu Cream + Glutathione Injection + NAD+ Injection | From $349/mo | A skin-and-cellular-support protocol after clinician review |
| Weight + Energy | NAD+ Injection + choice of GLP-1 | From $309/mo | A weight-focused protocol for eligible patients when a GLP-1 is appropriate |
Medications are compounded in the US by state-licensed 503A compounding pharmacies and shipped to the patient's door. Chia also offers NAD+ within Foundation Longevity, Glow, and Weight + Energy protocols for eligible patients.
How should someone choose between oral NAD+ and clinician-guided NAD+?
Start with your goal and risk profile. Oral NAD+ precursors may fit someone who wants a simple supplement routine, while clinician-guided NAD+ may fit someone who wants medical review, prescription oversight, and a licensed pharmacy source.
- What are you hoping to change: fatigue, metabolic markers, exercise recovery, or general longevity support?
- Are you pregnant, trying to conceive, breastfeeding, or managing a complex medical condition?
- What medications and supplements do you already use?
- Do you have a history of injection reactions, severe allergies, or sensitivity to compounded ingredients?
- Is the product coming from a licensed pharmacy or a no-prescription online source?
- Are you comfortable with injections, or would a non-injection option such as nasal spray or oral supplementation fit better?
Avoid self-directed injection use. Sterile injectable products carry risks that oral supplements do not, including contamination and endotoxin exposure when ingredients are not suitable for sterile compounding 8.
3-min quiz
Start with a licensed-provider review
If you are comparing oral NAD+ supplements with clinician-guided NAD+ injection or nasal spray, Chia can review your goals and health history online. Prescriptions are issued only when clinically appropriate and are not guaranteed.
Frequently asked questions about NAD+ injections vs oral NAD+
There is no proven single best form for everyone. Oral NR and NMN have human biomarker data, while injections bypass digestion but require sterile compounding and clinician oversight. The right route depends on your goals, health history, tolerance, and access to a licensed source.
Oral NAD-support products can be effective at raising NAD-related biomarkers, especially when they contain precursors such as NR or NMN. That does not mean they are proven to improve energy, reduce fat, or extend human lifespan.
No. NAD+ injections and NAD+ IV infusions both bypass digestion, but they use different delivery methods. IV therapy is delivered into a vein and is usually visit-based and monitored; injections are typically shorter and may be prescribed for eligible patients under clinician guidance.
NAD+ should not be viewed as a stand-alone belly-fat or weight-loss treatment. Some studies look at metabolic markers, but that is not the same as proven fat loss. If weight is your main concern, a clinician should evaluate weight-focused options separately.
There is no guaranteed timeline. Some people seek NAD+ injections because the route bypasses digestion, but symptom changes vary and are not assured. A clinician can help set realistic expectations based on your health history and goals.
No. Compounded NAD+ injections are not FDA-approved. They may be prescribed when a licensed clinician determines they are appropriate, and they should come from a state-licensed compounding pharmacy using ingredients suitable for sterile compounding.
Do not combine NAD+ products on your own. A clinician should review your supplement list, medications, symptoms, and health history before combining oral precursors with injectable or nasal NAD+.
NAD+ injections may not be appropriate for people with certain medical conditions, medication conflicts, pregnancy-related concerns, prior injection reactions, or allergy risks. Eligibility should be decided by a licensed clinician after reviewing your health history.
References
- 1.Poddar SK, Sifat AE, Haque S, Nahid NA, Chowdhury S, Mehedi I. Nicotinamide mononucleotide: exploration of diverse therapeutic applications of a potential molecule. Biomolecules, 2019.
- 2.Covarrubias AJ, Perrone R, Grozio A, Verdin E. NAD+ metabolism and its roles in cellular processes during ageing. Nature Reviews Molecular Cell Biology, 2021.
- 3.Katsyuba E, Romani M, Hofer D, Auwerx J. NAD+ homeostasis in health and disease. Nature Metabolism, 2020.
- 4.Trammell SAJ, Schmidt MS, Weidemann BJ, et al. Nicotinamide riboside is uniquely and orally bioavailable in mice and humans. Nature Communications, 2016.
- 5.Martens CR, Denman BA, Mazzo MR, et al. Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults. Nature Communications, 2018.
- 6.Yoshino M, Yoshino J, Kayser BD, et al. Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women. Science, 2021.
- 7.Dollerup OL, Christensen B, Svart M, et al. A randomized placebo-controlled clinical trial of nicotinamide riboside in obese men: safety, insulin-sensitivity, and lipid-mobilizing effects. American Journal of Clinical Nutrition, 2018.
- 8.U.S. Food and Drug Administration. FDA reminds compounders to use ingredients suitable for sterile compounding. FDA, 2024.
- 9.Igarashi M, Miura M, Williams E, et al. Nicotinamide mononucleotide supplementation improves physical performance in healthy old men. NPJ Aging, 2022.
About this article
Chia Health Editorial Team — Evidence-reviewed health education
This article is for educational purposes only and is not a substitute for individualized medical advice. Talk to a licensed clinician before starting, stopping, or changing any prescription.
AI tools may assist with research and drafting. Chia's editorial team reviews source use, clarity, treatment information, and safety framing before publication. A clinician is named only after explicit sign-off. Read our editorial standards.
Get a personalized plan
See if NAD+ is right for your body.
Our 3-minute clinical quiz is reviewed by a US-licensed clinician. Treatment delivered to your door.



